ArticleAntibiotics (Basel, Switzerland)2024

Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn's Disease.

David Y Graham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.